Search the Protocols

List of Donors

Make a donation to the protocols online

KLS Martin, LP

Hemostatix Medical Technologies, LLC

Boston Medical Products Inc.


Jon and Veda Foster


Synovis Micro Companies Alliance, Inc

Tom Benda, JR., M.D.

The Potash Family

UIHC Melanoma and Sarcoma Tissue Bank

Karl Storz-Endoskope

Heartland Regional Chapter of SOHN

The Department of Otolaryngology and the University of Iowa wish to acknowledge the support of those who share our goal in improving the care of patients we serve. The University of Iowa appreciates that supporting benefactors recognize the University of Iowa's need for autonomy in the development of the content of the Iowa Head and Neck Protocols.

HaN Admin Pages

You are being sent to:
Skip to end of metadata
Go to start of metadata

Retromolar Trigone Squamous Cell Carcinoma

  •  The fourth most common oral cavity and oropharynx malignancy (6% of cases), grouped with gingival SCCa due to similar history and management
  •  Most telling diagnostic clue is the obliteration of buccal fat behind the parotid duct
  •  Will spread via the pterygomandibular raphe which is loacted deep to the retromolar trigone
  •  The pterygomandibular raphe is an important anatomical marker in cases of retromolar trigone SCCa
    •  The pterygomandibular raphe attaches superiorly to the pterygoid hamulus, allowing tumor spread to base of skull or masticator space
    •  The pterygomandibular raphe attaches inferiorly to the mylohyoid line of the mandible allowing for tumor spread to the floor of mouth
  •  Most common nodal involvement includes levels I, II, and III
  •  Ipsilateral nodal involvement seen in 39-56% of cases at presentation
  •  Contralateral nodal involvement is seen in 8.8% of cases

  • No labels